Rock Springs Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.17M | Sell |
68,600
-90,700
| -57% | -$1.55M | 0.07% | 83 |
|
2025
Q1 | $10.2M | Sell |
159,300
-148,200
| -48% | -$9.46M | 0.58% | 50 |
|
2024
Q4 | $37.4M | Hold |
307,500
| – | – | 1.42% | 25 |
|
2024
Q3 | $38.4M | Buy |
307,500
+23,500
| +8% | +$2.93M | 1.25% | 31 |
|
2024
Q2 | $44.9M | Sell |
284,000
-43,600
| -13% | -$6.89M | 1.35% | 30 |
|
2024
Q1 | $42.4M | Hold |
327,600
| – | – | 1.08% | 35 |
|
2023
Q4 | $31.6M | Sell |
327,600
-64,400
| -16% | -$6.21M | 0.78% | 43 |
|
2023
Q3 | $47.5M | Sell |
392,000
-33,000
| -8% | -$4M | 1.27% | 28 |
|
2023
Q2 | $48.7M | Sell |
425,000
-17,500
| -4% | -$2M | 1.16% | 29 |
|
2023
Q1 | $61M | Buy |
442,500
+6,500
| +1% | +$896K | 1.46% | 25 |
|
2022
Q4 | $56.5M | Buy |
436,000
+6,000
| +1% | +$777K | 1.36% | 26 |
|
2022
Q3 | $47.5M | Buy |
430,000
+2,000
| +0.5% | +$221K | 1.23% | 25 |
|
2022
Q2 | $32.1M | Hold |
428,000
| – | – | 0.93% | 39 |
|
2022
Q1 | $33.4M | Buy |
428,000
+4,000
| +0.9% | +$312K | 0.84% | 40 |
|
2021
Q4 | $38.2M | Buy |
424,000
+74,000
| +21% | +$6.66M | 0.88% | 38 |
|
2021
Q3 | $32.4M | Buy |
350,000
+21,250
| +6% | +$1.97M | 0.68% | 49 |
|
2021
Q2 | $25.6M | Hold |
328,750
| – | – | 0.51% | 63 |
|
2021
Q1 | $24.5M | Hold |
328,750
| – | – | 0.53% | 64 |
|
2020
Q4 | $56M | Sell |
328,750
-16,750
| -5% | -$2.86M | 1.19% | 26 |
|
2020
Q3 | $48.5M | Hold |
345,500
| – | – | 1.23% | 28 |
|
2020
Q2 | $55.4M | Hold |
345,500
| – | – | 1.52% | 14 |
|
2020
Q1 | $33.8M | Hold |
345,500
| – | – | 1.4% | 24 |
|
2019
Q4 | $44.6M | Buy |
345,500
+8,000
| +2% | +$1.03M | 1.41% | 15 |
|
2019
Q3 | $25.4M | Buy |
337,500
+12,500
| +4% | +$942K | 1.01% | 32 |
|
2019
Q2 | $49.4M | Sell |
325,000
-9,500
| -3% | -$1.44M | 1.79% | 11 |
|
2019
Q1 | $39.9M | Buy |
334,500
+7,500
| +2% | +$894K | 1.54% | 12 |
|
2018
Q4 | $35.7M | Buy |
327,000
+16,500
| +5% | +$1.8M | 1.68% | 12 |
|
2018
Q3 | $50.1M | Buy |
310,500
+13,000
| +4% | +$2.1M | 1.82% | 12 |
|
2018
Q2 | $39.3M | Buy |
297,500
+39,500
| +15% | +$5.22M | 1.51% | 15 |
|
2018
Q1 | $19.1M | Hold |
258,000
| – | – | 0.82% | 42 |
|
2017
Q4 | $14.4M | Sell |
258,000
-1,200
| -0.5% | -$66.8K | 0.65% | 57 |
|
2017
Q3 | $11.8M | Buy |
259,200
+54,200
| +26% | +$2.46M | 0.54% | 61 |
|
2017
Q2 | $6.91M | Buy |
205,000
+11,000
| +6% | +$371K | 0.35% | 83 |
|
2017
Q1 | $5.74M | Buy |
194,000
+2,100
| +1% | +$62.2K | 0.33% | 85 |
|
2016
Q4 | $5.26M | Buy |
191,900
+18,900
| +11% | +$518K | 0.35% | 76 |
|
2016
Q3 | $10.6M | Buy |
173,000
+42,000
| +32% | +$2.58M | 0.67% | 51 |
|
2016
Q2 | $2.5M | Hold |
131,000
| – | – | 0.18% | 109 |
|
2016
Q1 | $2.56M | Buy |
131,000
+23,500
| +22% | +$459K | 0.21% | 105 |
|
2015
Q4 | $4.15M | Buy |
+107,500
| New | +$4.15M | 0.31% | 95 |
|